Cargando…

Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review

BACKGROUND: Generalised joint hypermobility (GJH) is highly prevalent among children and associated with symptoms in a fifth with the condition. This study aimed to synthesise outcome measures in interventional or prospective longitudinal studies of children with GJH and associated lower limb sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Maarj, Muhammad, Coda, Andrea, Tofts, Louise, Williams, Cylie, Santos, Derek, Pacey, Verity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628404/
https://www.ncbi.nlm.nih.gov/pubmed/34839813
http://dx.doi.org/10.1186/s12887-021-03009-z
_version_ 1784607000153292800
author Maarj, Muhammad
Coda, Andrea
Tofts, Louise
Williams, Cylie
Santos, Derek
Pacey, Verity
author_facet Maarj, Muhammad
Coda, Andrea
Tofts, Louise
Williams, Cylie
Santos, Derek
Pacey, Verity
author_sort Maarj, Muhammad
collection PubMed
description BACKGROUND: Generalised joint hypermobility (GJH) is highly prevalent among children and associated with symptoms in a fifth with the condition. This study aimed to synthesise outcome measures in interventional or prospective longitudinal studies of children with GJH and associated lower limb symptoms. METHODS: Electronic searches of Medline, CINAHL and Embase databases from inception to 16th March 2020 were performed for studies of children with GJH and symptoms between 5 and 18 years reporting repeated outcome measures collected at least 4 weeks apart. Methodological quality of eligible studies were described using the Downs and Black checklist. RESULTS: Six studies comprising of five interventional, and one prospective observational study (total of 388 children) met the inclusion criteria. Interventional study durations were between 2 and 3 months, with up to 10 months post-intervention follow-up, while the observational study spanned 3 years. Three main constructs of pain, function and quality of life were reported as primary outcome measures using 20 different instruments. All but one measure was validated in paediatric populations, but not specifically for children with GJH and symptoms. One study assessed fatigue, reporting disabling fatigue to be associated with higher pain intensity. CONCLUSIONS: There were no agreed sets of outcome measures used for children with GJH and symptoms. The standardisation of assessment tools across paediatric clinical trials is needed. Four constructs of pain, function, quality of life and fatigue are recommended to be included with agreed upon, validated, objective tools.
format Online
Article
Text
id pubmed-8628404
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86284042021-12-01 Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review Maarj, Muhammad Coda, Andrea Tofts, Louise Williams, Cylie Santos, Derek Pacey, Verity BMC Pediatr Research Article BACKGROUND: Generalised joint hypermobility (GJH) is highly prevalent among children and associated with symptoms in a fifth with the condition. This study aimed to synthesise outcome measures in interventional or prospective longitudinal studies of children with GJH and associated lower limb symptoms. METHODS: Electronic searches of Medline, CINAHL and Embase databases from inception to 16th March 2020 were performed for studies of children with GJH and symptoms between 5 and 18 years reporting repeated outcome measures collected at least 4 weeks apart. Methodological quality of eligible studies were described using the Downs and Black checklist. RESULTS: Six studies comprising of five interventional, and one prospective observational study (total of 388 children) met the inclusion criteria. Interventional study durations were between 2 and 3 months, with up to 10 months post-intervention follow-up, while the observational study spanned 3 years. Three main constructs of pain, function and quality of life were reported as primary outcome measures using 20 different instruments. All but one measure was validated in paediatric populations, but not specifically for children with GJH and symptoms. One study assessed fatigue, reporting disabling fatigue to be associated with higher pain intensity. CONCLUSIONS: There were no agreed sets of outcome measures used for children with GJH and symptoms. The standardisation of assessment tools across paediatric clinical trials is needed. Four constructs of pain, function, quality of life and fatigue are recommended to be included with agreed upon, validated, objective tools. BioMed Central 2021-11-29 /pmc/articles/PMC8628404/ /pubmed/34839813 http://dx.doi.org/10.1186/s12887-021-03009-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Maarj, Muhammad
Coda, Andrea
Tofts, Louise
Williams, Cylie
Santos, Derek
Pacey, Verity
Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title_full Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title_fullStr Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title_full_unstemmed Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title_short Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
title_sort outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628404/
https://www.ncbi.nlm.nih.gov/pubmed/34839813
http://dx.doi.org/10.1186/s12887-021-03009-z
work_keys_str_mv AT maarjmuhammad outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview
AT codaandrea outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview
AT toftslouise outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview
AT williamscylie outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview
AT santosderek outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview
AT paceyverity outcomemeasuresforassessingchangeovertimeinstudiesofsymptomaticchildrenwithhypermobilityasystematicreview